Hanlon Suzanne M. 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Aug 7, 2018
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Purchase
Common Stock
2018-08-06$5.80/sh+3,800$22,048→ 43,693 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.71 to $5.89, inclusive. The reporting person undertakes to provide Zynerba Pharmaceuticals, Inc., any security holder of Zynerba Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.